Abstract:Introduction: It is known that patients with immune-abnormal co-pregnancies are at a higher risk of adverse pregnancy outcomes. Traditional pregnancy risk management systems have poor prediction abilities for adverse pregnancy outcomes in such patients, with many limitations in clinical application. In this study, we will use machine learning to screen high-risk factors for miscarriage and develop a miscarriage risk prediction model for patients with immune-abnormal pregnancies. This model aims to provide an adjunctive tool for the clinical identification of patients at high risk of miscarriage and to allow for active intervention to reduce adverse pregnancy outcomes. Methods: Patients with immune-abnormal pregnancies attending Sichuan Provincial People's Hospital were collected through electronic medical records (EMR). The data were divided into a training set and a test set in an 8:2 ratio. Comparisons were made to evaluate the performance of traditional pregnancy risk assessment tools for clinical applications. This analysis involved assessing the cost-benefit of clinical treatment, evaluating the model's performance, and determining its economic value. Data sampling methods, feature screening, and machine learning algorithms were utilized to develop predictive models. These models were internally validated using 10-fold cross-validation for the training set and externally validated using bootstrapping for the test set. Model performance was assessed by the area under the characteristic curve (AUC). Based on the best parameters, a predictive model for miscarriage risk was developed, and the SHapley additive expansion (SHAP) method was used to assess the best model feature contribution. Results: A total of 565 patients were included in this study on machine learning-based models for predicting the risk of miscarriage in patients with immune-abnormal pregnancies. Twenty-eight risk warning models were developed, and the predictive model constructed using XGBoost demonstrated the best performance with an AUC of 0.9209. The SHAP analysis of the best model highlighted the total number of medications, as well as the use of aspirin and low molecular weight heparin, as significant influencing factors. The implementation of the pregnancy risk scoring rules resulted in accuracy, precision, and F1 scores of 0.3009, 0.1663, and 0.2852, respectively. The economic evaluation showed a saving of ¥7,485,865.7 due to the model. Conclusion: The predictive model developed in this study performed well in estimating the risk of miscarriage in patients with immune-abnormal pregnancies. The findings of the model interpretation identified the total number of medications and the use of other medications during pregnancy as key factors in the early warning model for miscarriage risk. This provides an important basis for early risk assessment and intervention in immune-abnormal pregnancies. The predictive model developed in this study demonstrated better risk prediction performance than the Pregnancy Risk Management System (PRMS) and also demonstrated economic value. Therefore, miscarriage risk prediction in patients with immune-abnormal pregnancies may be the most cost-effective management method.

Assessing the Effect of Vaccine on Spontaneous Abortion Using Time-Dependent Covariates Cox Models

Time-dependent Propensity Score for Assessing the Effect of Vaccine Exposure on Pregnancy Outcomes Through Pregnancy Exposure Cohort Studies.

A joint analysis proposal of nonlinear longitudinal and time-to-event right-, interval-censored data for modeling pregnancy miscarriage

Semiparametric Sieve Maximum Likelihood Estimation Under Cure Model with Partly Interval Censored and Left Truncated Data for Application to Spontaneous Abortion Data

Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 Seasonal Influenza Vaccines in Pregnancy: Birth Defects, Spontaneous Abortion, Preterm Delivery, and Small for Gestational Age Infants, A Study from the Cohort Arm of Vampss

Lack of association between COVID-19 vaccines and miscarriage onset using a case-crossover design

Peri-conceptional or pregnancy exposure of HPV vaccination and the risk of spontaneous abortion: a systematic review and meta-analysis

Causal Inference Over a Subpopulation: The Effect of Malaria Vaccine in Women During Pregnancy

Modeling the Risk Factors of Miscarriage Using Survival Analysis Techniques

The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: a Systematic Review and Meta-Analysis

A Signal Detection Method for Temporal Variation of Adverse Effect with Vaccine Adverse Event Reporting System Data

Inactivated COVID-19 Vaccines in Peri-Pregnancy Period: Evaluation of Safety for Both Pregnant Women and Neonates.

A study examining the correlation between serum 25-OH-VitD levels, CD3-CD19+ B lymphocytes, and the risk of early spontaneous abortion in pregnant women

Risk prediction model based on machine learning for predicting miscarriage among pregnant patients with immune abnormalities

Non-linear Relationship of Maternal Age With Risk of Spontaneous Abortion: A Case-Control Study in the China Birth Cohort

Maternal Age And Serum Beta-Hcg Concentrations At 14-16 Days After Embryo Transfer Are Predictive Factors For Spontaneous Abortion In Ivf/Icsi Cycles In Northeast China

Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study

A Systematic Review and Meta‐analysis of Fetal Outcomes Following the Administration of Influenza A/H1N1 Vaccination During Pregnancy

One “misunderstood” health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis

Association of different types of abortions with neonatal outcomes in subsequent pregnancy

Proportional Change of Cd4(+)Cd25(+) Regulatory T Cells in Decidua and Peripheral Blood in Unexplained Recurrent Spontaneous Abortion Patients